Institutional Analysis
Pinpoint the centers of excellence that drive treatment adoption and influence care standards.
Within3 combines claims and scientific data to identify leading institutions—academic, clinical, and practice-based—so Medical Affairs and Commercial teams can align global and regional strategies, strengthen key relationships, and accelerate growth.
With Within3, you can:
Identify true centers of excellence by patient volume, scientific output, or referral impact.
Deep-dive into priority accounts to surface key institutional characteristics.
Map geographical clusters and regional variations to guide global and local engagement.
Equip field teams with the intelligence to strengthen relationships before and after launch.
Extend institutional influence through virtual engagement, advisory, and training programs.
The result: a unified, data-driven view of the institutions that matter most—empowering stronger partnerships, consistent global strategies, and measurable impact.
Case Study: Identify global centers of excellence for rare disease launch
Challenge
A medical affairs team preparing to launch a rare disease therapy faced a global challenge. With the drug in Phase 3 trials, they needed to engage the most influential academic institutions worldwide to ensure strong adoption. Without a unified view of global centers of excellence, regional teams risked inconsistent engagement strategies.
The solution
Within3 was able to identify KOLs associated with the main KOL centers in Europe, North America, and Asia pertaining to the specific disease area.
Outcome: The key Institutions and geographical clusters of interest were identified.
- Prioritized engagement around true centers of excellence.
- Improved alignment across global and regional field teams.
- Built stronger relationships with leading institutions before launch.
Case Study: Mapping U.S. centers of excellence to support growth
Challenge
For a commercial team marketing a wearable drug delivery device, identifying U.S. centers of excellence was key to expanding adoption. The challenge was twofold: understanding which institutions drove patient volume and which scientific leaders influenced adoption through research.
The solution
Within3 combined scientific publication analysis with U.S. claims data to surface both academic and practice institutions of influence
Beyond the mapping, the client leveraged Within3’s virtual engagement platform to host community meetings, online events, and training sessions—building a support system around the device’s adoption.
Outcome: Extended influence through ongoing virtual engagement.
- Identified both scientific and practice centers of excellence.
- Equipped the team to target both research leaders and high-volume practices.
- Strengthened post-mapping engagement through virtual collaboration tools
Unlock the power of Launch Intelligence™
Discover how scattered data becomes a real-time market view, delivering the speed and confidence your launch demands.
